Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Curis Lifesciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Curis Lifesciences IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 10.29 and post-issue EPS of ₹ 7.55 for FY25. The pre-issue P/E ratio is 12.44x, while the post-issue P/E ratio is 16.95x against the Industry P/E ratio is 23x. The company's ROE for FY25 is 55.25% and RoNW is 37.62%. The Annualised EPS is ₹ 10.66x and P/E is 12.01x. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 10.29 |
| EPS Post IPO (Rs.) | 7.55 |
| Adjusted 12M EPS Post IPO (Rs.) | 10.66 |
| P/E Pre IPO | 12.44 |
| P/E Post IPO | 16.95 |
| Adjusted 12M P/E Post IPO | 12.01 |
| ROE | 55.25% |
| ROCE | 27.83% |
| P/BV | 4.68 |
| Debt/Equity | 0.96 |
| RoNW | 37.62 |
| EBITDA Margin | 19.41% |
| PAT Margin | 12.30% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
